Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Clinical Outcomes and Resource Utilization Over 10 Years of Institutional Treatment Practice Changes in Pediatric Asthma Exacerbations.

Created on 14 Nov 2026

Authors

Dokfai Kaewwaew, Wanaporn Anuntaseree, Kanokpan Ruangnapa, Kantara Saelim, Pharsai Prasertsan, Kantisa Sirianansopa

Published in

Pediatric pulmonology. Volume 61. Issue 11.

Abstract

To evaluate changes in clinical outcomes and resource utilization associated with changes in institutional practice for the management of acute asthma exacerbations in children over a 10-year study period.
This retrospective cohort study included children aged 2-15 years hospitalized for moderate-to-severe asthma exacerbations from 2016 to 2025 (n = 329). Patients were categorized according to the institutional treatment strategy implemented during different periods of the study; conventional oxygen therapy with bronchodilator delivery using a jet nebulizer (JN group), n = 196), high flow nasal cannula oxygen therapy with bronchodilator via JN (HFNC-JN group; n = 80), and HFNC with an in-line vibrating mesh nebulizer (HFNC-VN group; n = 53). Inverse probability of treatment weighting was used to adjust for baseline differences among the groups.
The median hospital length of stay differed significantly among the JN, HFNC-JN, and HFNC-VN groups: 59 (interquartile range [IQR], 44, 71), 64 (IQR, 55, 91), and 78 (IQR, 55, 101) h, respectively (p < 0.001). The corresponding percent change in respiratory rate at 24 h differed significantly: -12.5% (IQR, -22.2%, -4.9%), -22.2% (IQR, -31.0%, 0.0%), and -19.6% (IQR, -29.4%, -10.8%) (p = 0.038). The HFNC-VN group received higher cumulative salbutamol doses at 1, 6, 12, 24, and 48 h and incurred the highest treatment costs.
Changes in institutional treatment practices for asthma exacerbation, including oxygen therapy, respiratory support, bronchodilator administration, and weaning practices, were associated with longer hospital stays and higher total treatment costs. These findings provide real-world evidence supporting the need for standardized treatment practices and development of evidence-based treatment protocols.

PMID:
43024401
Bibliographic data and abstract were imported from PubMed on 14 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement